Zentalis Pharmaceuticals (ZNTL) P/E (2020 - 2026)
Zentalis Pharmaceuticals (ZNTL) P/E from Jun 30, 2020 to Jul 21, 2026. The TTM Zentalis Pharmaceuticals (ZNTL) P/E is -2.87. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Zentalis Pharmaceuticals (ZNTL)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.87 | +308.09% |
| 2025 | -0.70 | -46.01% |
| 2024 | -1.30 | -62.48% |
| 2023 | -3.47 | -21.68% |
| 2022 | -4.43 | -80.36% |
| 2021 | -22.54 | +12.00% |
| 2020 | -20.12 | N/A |
Comparison Zentalis Pharmaceuticals (ZNTL) P/E with competitors
Zentalis Pharmaceuticals (ZNTL) P/E is -2.87.